Munich Re's Julie Scott discusses how the critical illness industry could break the cycle of competing on conditions.
The critical illness market remains driven by definitions as 2015 sees insurers facing an ABI deadline and advisers with a need for 'complex' knowledge, writes Thomas Smith
There are 1.8m cancer patients with another long term health condition, research from Macmillan Cancer Support has revealed.
Macmillan Cancer Support has welcomed aspects of the manifestos of the Greens, LibDems and UKIP.
Macmillan Cancer Support has welcomed the Conservatives' manifesto pledges for cancer patients, including changes to improve survival rates.
Friends Life has revealed that for the first time it paid out more in critical illness claims than for life insurance during 2014.
Shorter people are more likely to have coronary heart disease, research from the University of Leicester has found.
Aviva's latest changes to its critical illness (CI) policy has bought it into line with ‘market leaders' Friends Life and Old Mutual Wealth, CIExpert has said.
Cancer survival rates in the UK are at or behind levels other European countries had achieved by the late 1990s, analysis by Macmillan Cancer Support has found.
CIExpert has described Friends Life's changes to its critical illness (CI) product as offering 'a number of significant improvements'.